+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pyrimethamine"

Artemisinin Combination Therapy Market Size, Share and Trends Analysis Report by Type (Artemether+Lumefantrine, Artesunate+Amodiaquine), and Region 2024-2030 - Product Thumbnail Image

Artemisinin Combination Therapy Market Size, Share and Trends Analysis Report by Type (Artemether+Lumefantrine, Artesunate+Amodiaquine), and Region 2024-2030

  • Report
  • September 2024
  • 100 Pages
  • Global
From
Artemisinin Combination Therapy Market by Active Ingredient, Dosage Form, End User, Distribution Channel, Patient Group - Global Forecast to 2030 - Product Thumbnail Image

Artemisinin Combination Therapy Market by Active Ingredient, Dosage Form, End User, Distribution Channel, Patient Group - Global Forecast to 2030

  • Report
  • May 2025
  • 196 Pages
  • Global
From
Toxoplasmosis Treatment Drugs Market Report 2025 - Product Thumbnail Image

Toxoplasmosis Treatment Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Artemisinin Combination Therapy - Global Strategic Business Report - Product Thumbnail Image

Artemisinin Combination Therapy - Global Strategic Business Report

  • Report
  • July 2025
  • 194 Pages
  • Global
From
Anti-Malarial Medicines - Global Strategic Business Report - Product Thumbnail Image

Anti-Malarial Medicines - Global Strategic Business Report

  • Report
  • July 2025
  • 288 Pages
  • Global
From
Antimalarial Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Antimalarial Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • June 2025
  • 185 Pages
  • Global
From
Artemisinin Combination Therapy Market - Growth, Trends, and Forecasts (2023 - 2028) - Product Thumbnail Image

Artemisinin Combination Therapy Market - Growth, Trends, and Forecasts (2023 - 2028)

  • Report
  • April 2023
  • 111 Pages
  • Global
From
Toxoplasmosis - Pipeline Review, H1 2020 - Product Thumbnail Image

Toxoplasmosis - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 48 Pages
  • Global
From
Africa Artemisinin Combination Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

Africa Artemisinin Combination Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 100 Pages
  • Africa
From
Artemisinin Combination Therapy Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030 - Product Thumbnail Image

Artemisinin Combination Therapy Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

  • Report
  • December 2023
  • 180 Pages
  • Global
From
United States Artemisinin Combination Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

United States Artemisinin Combination Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • United States
From
South Korea Artemisinin Combination Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

South Korea Artemisinin Combination Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • South Korea
From
Saudi Arabia Artemisinin Combination Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

Saudi Arabia Artemisinin Combination Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • Saudi Arabia
From
Germany Artemisinin Combination Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

Germany Artemisinin Combination Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • Germany
From
France Artemisinin Combination Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

France Artemisinin Combination Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • France
From
China Artemisinin Combination Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

China Artemisinin Combination Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • China
From
United Kingdom Artemisinin Combination Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

United Kingdom Artemisinin Combination Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • United Kingdom
From
United Arab Emirates Artemisinin Combination Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

United Arab Emirates Artemisinin Combination Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • United Arab Emirates United Arab Emirates
From
Pyrimethamine Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Pyrimethamine Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2023
  • 90 Pages
  • Global
From
Toxoplasmosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Toxoplasmosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 44 Pages
  • Global
From
Loading Indicator

Pyrimethamine is an antifolate drug used to treat a variety of infectious diseases, including toxoplasmosis, malaria, and isoniazid-resistant tuberculosis. It is also used to prevent and treat Pneumocystis jirovecii pneumonia in people with weakened immune systems. Pyrimethamine is available in both oral and injectable forms, and is often used in combination with other drugs. The pyrimethamine market is driven by the increasing prevalence of infectious diseases, the growing demand for combination therapies, and the increasing availability of generic drugs. The market is also driven by the increasing number of clinical trials and the development of new formulations. Companies in the pyrimethamine market include GlaxoSmithKline, Pfizer, Merck, Sanofi, Novartis, and Mylan. Show Less Read more